BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Geschäft · 8.10.19981 Min. Lesezeit

Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

The Food and Drug Administration (FDA) is amending its regulations governing the submission and review of premarket approval (PMA) supplements to provide for the submission of a 30-day notice for modifications to manufacturing procedures or methods of manufacture. Amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Food and Drug Administration Modernization Act of 1997 (FDAMA).

Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →

Weitere Themen

Business-Analysen →